Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:24 pm Sale | 2024-09-30 | 13G | Janux Therapeutics, Inc. JANX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -4,579,818 (Position Closed) | Filing History |
| 2024-11-14 4:17 pm Sale | 2024-09-30 | 13G | Janux Therapeutics, Inc. JANX | CITADEL ADVISORS LLC | 1,021,403 2.000% | -2,104,494 (-67.32%) | Filing History |
| 2024-11-14 4:01 pm Purchase | 2024-09-30 | 13G | Janux Therapeutics, Inc. JANX | Campbell David Alan | 2,644,622 4.800% | 99,547 (+3.91%) | Filing History |
| 2024-11-12 10:32 am Purchase | 2024-11-08 | 13G | Janux Therapeutics, Inc. JANX | FMR LLC | 7,824,674 14.999% | 3,153,461 (+67.51%) | Filing History |
| 2024-11-08 5:58 pm Sale | 2024-11-06 | 13D | Janux Therapeutics, Inc. JANX | Avalon Ventures XI L.P. | 2,146,482 4.100% | -1,943,836 (-47.52%) | Filing History |
| 2024-11-04 4:05 pm Sale | 2024-09-30 | 13G | Janux Therapeutics, Inc. JANX | Bregua Corp | 2,999,990 5.800% | -830,267 (-21.68%) | Filing History |
| 2024-10-25 5:28 pm Sale | 2024-10-23 | 13D | Janux Therapeutics, Inc. JANX | Avalon Ventures XI L.P. | 4,090,318 7.800% | -548,408 (-11.82%) | Filing History |
| 2024-10-23 5:39 pm Purchase | 2024-10-16 | 13G | Janux Therapeutics, Inc. JANX | Paradigm Biocapital Advisors LP | 2,608,574 5.000% | 2,608,574 (New Position) | Filing History |
| 2024-10-22 4:17 pm Sale | 2024-10-18 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,443,181 19.990% | -299,812 (-2.79%) | Filing History |
| 2024-10-22 4:16 pm Sale | 2024-10-18 | 13D | Janux Therapeutics, Inc. JANX | Avalon Ventures XI L.P. | 4,638,726 8.900% | -1,983,341 (-29.95%) | Filing History |
| 2024-09-16 9:41 pm Sale | 2024-09-12 | 13D | Janux Therapeutics, Inc. JANX | Avalon Ventures XI L.P. | 6,622,067 12.700% | -682,423 (-9.34%) | Filing History |
| 2024-09-16 9:35 pm Purchase | 2024-09-12 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,742,993 19.990% | 149,598 (+1.41%) | Filing History |
| 2024-08-09 4:09 pm Sale | 2024-07-31 | 13D | Janux Therapeutics, Inc. JANX | ORBIMED ADVISORS LLC | 1,965,266 3.800% | -684,198 (-25.82%) | Filing History |
| 2024-06-05 7:28 pm Sale | 2024-06-03 | 13D | Janux Therapeutics, Inc. JANX | Avalon Ventures XI L.P. | 7,304,490 14.100% | -1,496,249 (-17.00%) | Filing History |
| 2024-03-06 6:54 pm Purchase | 2024-03-04 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,593,395 19.990% | 1,922,751 (+22.18%) | Filing History |
| 2024-03-04 8:07 pm Sale | 2024-02-29 | 13D | Janux Therapeutics, Inc. JANX | Avalon Ventures XI L.P. | 8,800,739 17.100% | -965,615 (-9.89%) | Filing History |
| 2024-02-14 5:53 pm Sale | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | EcoR1 Capital LLC | 0 0.000% | -3,255,270 (Position Closed) | Filing History |
| 2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | CITADEL ADVISORS LLC | 3,125,897 6.800% | 999,762 (+47.02%) | Filing History |
| 2024-02-14 09:43 am Purchase | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | BIOTECHNOLOGY VALUE FUND L P | 4,579,818 9.900% | 472,873 (+11.51%) | Filing History |
| 2024-02-09 4:31 pm Purchase | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | Campbell David Alan | 2,545,075 5.300% | 165,140 (+6.94%) | Filing History |